SEC Form 4Coverage since Jul 23, 2026
$SCTX insider trading
Over the last 12 months, Scribe Therapeutics insiders reported 6 buys totaling $71.3M and no sales across SEC Form 4 filings.
- Bought · 12m
- $71.3M 6 events
- Sold · 12m
- — 0 events
- Events · 12m
- 6 Form 4 filings, grouped
- Insiders · 12m
- 6 distinct reporters
- 10b5-1 share
- 0% pre-arranged plans
Side
Price · $SCTX · 12Mvia TradingView
Top insiders · 12m
Aghazadeh Behzad—1× · $36.3M
GORDON CARL L—1× · $15.0M
ORBIMED ADVISORS LLC—1× · $15.0M
AH Bio Fund II, L.P.—1× · $5.0M
Lucas SvetlanaChief Business Officer1× · $45K
All insider trades
6 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Jul 28, 2026 | Aghazadeh BehzadD·10% | ▲ Buy | 2,391,238 | $15.16 | $36.3M | +342.8% | 3 tranches · indirect |
| Jul 27, 2026 | AH Bio Fund II, L.P.10% | ▲ Buy | 333,333 | $15 | $5.0M | +16.2% | indirect |
| Jul 27, 2026 | GORDON CARL LD | ▲ Buy | 1,000,000 | $15 | $15.0M | +286.7% | indirect |
| Jul 27, 2026 | ORBIMED ADVISORS LLCD | ▲ Buy | 1,000,000 | $15 | $15.0M | +286.7% | indirect |
| Jul 23, 2026 | Lucas SvetlanaChief Business Officer · O | ▲ Buy | 3,000 | $15 | $45K | — | indirect |
| Jul 23, 2026 | Parrot DavidChief Financial Officer · O | ▲ Buy | 2,666 | $15 | $40K | — | 2 tranches · indirect |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $SCTX feed.